After KeyBanc and Robert W. Baird gave Phreesia (NYSE: PHR) a Buy rating last month, the company received another Buy, this time from Raymond James. Analyst John Ransom maintained a Buy rating on Phreesia today and set a price target of $30.00. The company’s shares closed last Friday at $24.20.
According to TipRanks.com, Ransom is a 5-star analyst with an average return of 6.6% and a 56.3% success rate. Ransom covers the Healthcare sector, focusing on stocks such as Community Health, HCA Healthcare, and UnitedHealth.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Phreesia with a $24.00 average price target, a -0.7% downside from current levels. In a report issued on April 13, Leerink Partners also initiated coverage with a Buy rating on the stock with a $24.00 price target.
See today’s analyst top recommended stocks >>
Based on Phreesia’s latest earnings release for the quarter ending January 31, the company reported a quarterly revenue of $32.82 million and GAAP net loss of $3.67 million. In comparison, last year the company earned revenue of $26.48 million and had a GAAP net loss of $5.08 million.
Based on the recent corporate insider activity of 60 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of PHR in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Phreesia, Inc. provides patient check-in solutions for medical practices. It provides solutions that transform the healthcare experience by engaging patients in their care and enabling healthcare provider organizations to optimize operational efficiency, improve profitability and enhance clinical care. Through the SaaS-based Phreesia Platform the company offers healthcare provider organizations a robust suite of solutions to manage the patient intake process and a payments solution for secure processing of patient payments. Its platform also provides life sciences companies with an engagement channel for targeted and direct communication with patients. Phreesia was founded by Chaim Indig and Evan Roberts in January 2005 and is headquartered in New York, NY.
